Small Business Resources, Business Advice and Forms from AllBusiness.com

Business Exchange

Research and Markets: by 2008, the Pharmaceutical Customer Relationship Management Market Will Grow to Be Approximately $625M...

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c9468) has announced the addition of Pharmaceutical Customer Relationship Management: Tools to Improve Sales Force Effectiveness & Productivity to their offering.

The pharmaceutical customer relationship management (CRM) market features a range of advanced software and hardware solutions specifically designed to increase the effectiveness and productivity of pharmaceutical sales representatives. As a result of strong competition and increasingly strict marketing guidelines, pharmaceutical companies are showing more interest in advanced CRM tools. However, market expansion will be limited by reductions in corporate spending, potential implementation hurdles, and the shortcomings of current hardware platforms.

The market segment is estimated to reach $455M in 2003 and growth is expected to continue at a moderate compound annual rate of nearly 6.5% to 2008. By 2008, the market will grow to be approximately $625M worldwide with regional distribution of U.S. 60%, Europe 30%, Japan 8%, and rest of the world with 2%.

This report includes an in-depth analysis of current CRM technologies and incorporates casestudies, company profiles, market trends, and identified challenges and strategic options for pharmaceutical companies seeking to advance their CRM capabilities. The study also provides a detailed description ofthe assumptions used to build the models for major company market shares and the industry-wide market forecast.

For a thorough analysis of this important market, the report:

-analyzes leading CRM software and mobile hardware technologies

-highlights a number of case studies-profiles sixteen major competitors

-provides a market forecast from 2003 to 2008 with detailed assumptions for each company and the industry as a whole

-identifies various market trends and implementation challenges

-provides strategic options for pharmaceutical companies interested in advancing their CRM capabilities

I. Executive Summary I-1

II. Objectives & Methodology II-1

III. Technical Overview III-1

IV. The Pharmaceutical CRM Tools Market IV-1

V. Trends and Challenges V-1

VI. Strategic Options VI-1

Appendix: A. Definitions A-1

For more information visit http://www.researchandmarkets.com/reports/c9468

In addition, make sure to read these articles:

  • Keeping Track of Your Prospective Customers
  • Quite simply... how do you do it? It is a topic near and dear to my heart - one of the biggest reasons people lose ......
  • What Kind of Cash Flow Management Do You Need?
  • Let's match up the kind of business you have with the most appropriate types of cash-flow management tools.
  • Ambience, Creativity, And Accessibility Enhance...
  • Tim Whelan, at Customer Service, What????? writes about an experience he had at a restaurant and how other businesses could learn from that "total customer ......
  • TargetRx Names Teresa Winslow Chief...
  • HORSHAM, Pa. -- Industry Veteran Brings More Than 25 Years Experience to Leading Pharmaceutical Marketing Information Services Company TargetRx, a marketing information services company ......
  • SYNAVANT Launches New Pharmaceutical Marketing...
  • Business Editors ATLANTA--(BUSINESS WIRE)--Aug. 1, 2002 New Thought Leader Network Identification Solution Provides Pharmaceutical Companies the Ability to Pursue the Right Physicians, with the Right ......
  • SYNAVANT Launches Physician Connect; A...
  • Business Editors ATLANTA--(BUSINESS WIRE)--Jan. 7, 2003 SYNAVANT Inc. (Nasdaq:SNVT), the global pioneer of pharmaceutical Customer Relationship Management (CRM) solutions for the biopharmaceutical and healthcare industries, ......
  • SYNAVANT Broadens Its Technology Solutions...
  • Business Editors ATLANTA--(BUSINESS WIRE)--Nov. 11, 2002 Partnership with update software AG Delivers premiere.update(SM) - a Suite of Technology Solution and Services Enabling Pharmaceutical Companies to ......
  • C3i Implements Siebel Pharma Analytics for...
  • Business Editors/High-Tech Writers SAN DIEGO--(BUSINESS WIRE)--Oct. 8, 2003 C3i, the market leader in customer management solutions for the life sciences industry, today announced at Siebel ......
  • Synavant Launches New Advanced Analytics Offering...
  • Business Editors ATLANTA--(BUSINESS WIRE)--Aug. 1, 2002 SYNAVANT's Global Strategic Solutions Group Partners with iNTERCON Systems to Develop Marketing Optimization Analysis Tool SYNAVANT, Inc. (Nasdaq:SNVT), the ......
  • SYNAVANT Launches New Implementation Toolkit to...
  • Business Editors ATLANTA--(BUSINESS WIRE)--Aug. 1, 2002 SYNAVANT Inc. (Nasdaq:SNVT), the global pioneer of pharmaceutical Customer Relationship Management (CRM) solutions for the biopharmaceutical and healthcare industries ......
  • SYNAVANT Establishes an Expert Consultancy Team.
  • Business Editors ATLANTA--(BUSINESS WIRE)--Feb. 19, 2002 New Global Strategic Solutions Team Focused on Helping Customers Achieve the Most from their Strategic Investments SYNAVANT Inc. (Nasdaq:SNVT), ......
  • CSSC Recently Completed Successful Siebel...
  • MORRISTOWN, N.J. -- CSSC, the leading regulatory compliance and validation company for the PDMA regulated industry, announced today that it has recently completed successful ......
  • CEGEDIM Signs Agreement for the Acquisition...
  • Business Editors/Health/Medical Writers PARIS--(BUSINESS WIRE)--March 17, 2003 CEGEDIM SA (CGDM.PA)(Euronext:CGM 5350) CEGEDIM SA (Euronext:CGM 5350), global provider of value added information and Customer Relationship Management ......
  • SYNAVANT to be Acquired by Groupe Cegedim for $2.
  • Business Editors ATLANTA--(BUSINESS WIRE)--April 12, 2003 SYNAVANT Inc. (Nasdaq:SNVT), a global leader in pharmaceutical Customer Relationship Management (CRM) and Interactive Marketing (IM) services for the ......
  • SYNAVANT Reports Second-Quarter 2002 Results.
  • Business Editors ATLANTA--(BUSINESS WIRE)--Aug. 1, 2002 EBITDA of $0.7 Million in Line With Guidance Range SYNAVANT Inc. (Nasdaq:SNVT), the global pioneer of pharmaceutical Customer Relationship ......